Koenig Sheldon L. 4
4 · Esperion Therapeutics, Inc. · Filed Jun 9, 2022
Insider Transaction Report
Form 4
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2022-06-07+91,000→ 91,000 totalExercise: $6.20Exp: 2032-06-07→ Common Stock (91,000 underlying)
Footnotes (1)
- [F1]Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label.